Profile
Theodore A.
Boutacoff was the founder who founded IRIDEX Corp.
in 1989 and served as its Chief Technology Officer from 2011 to 2013.
He also worked as a Director at Biotheranostics, Inc. Additionally, he received his undergraduate degree from Stanford University.
Former positions of Theodore A. Boutacoff
| Companies | Position | End |
|---|---|---|
| IRIDEX CORPORATION | Founder | 2013-01-31 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Director/Board Member | - |
Training of Theodore A. Boutacoff
| Stanford University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IRIDEX CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
- Stock Market
- Insiders
- Theodore A. Boutacoff
